SEC Form 4 · accession 0001179110-15-005996
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP, Corp & Med Affairs
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 1, 2015 | M | 5,000 | $19.085 | A | 152,422 | D | |
| Common StockF3 | Apr 1, 2015 | S | 3,600 | $96.3007 | D | 148,822 | D | |
| Common StockF4 | Apr 1, 2015 | S | 1,400 | $97.0615 | D | 147,422 | D | |
| Common StockF5 | Apr 1, 2015 | S | 1,325 | $96.2882 | D | 146,097 | D | |
| Common StockF6 | Apr 1, 2015 | S | 675 | $97.133 | D | 145,422 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $19.085 | Apr 1, 2015 | M | 5,000 | D | — | Jan 20, 2021 | Common Stock | 5,000 | 39,375 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- F3Sale prices reported for the transactions reported here range from $95.7981 to $96.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F4Sale prices reported for the transactions reported here range from $96.8008 to $97.71. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $95.73 to $96.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $96.78 to $97.60. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.